Compugen
Sector: Healthcare & Life Sciences
About Compugen
Decoding cancer biology, with its AI powered predictive computational discovery platform, Unigen™. Pioneered the discovery of the PVRIG and TIGIT pathways for cancer treatment.
Products
COM701 (Antibody); COM902; Predictive Discovery Engine
Advancing immuno-oncology with an AI/ML powered platform Immuno-oncology represents a paradigm shift in cancer treatment. Although current biological drugs can extend life expectancy for certain cancer types and patient populations, the potential of immuno-oncology remains largely untapped, with success rates of only 20-30% in specific cancer indications. We believe that the identification of novel drugs and biological pathways hold the potential to broaden the reach of cancer immunotherapies to more cancer patients.